Hamilelikte dimethyl imidazolidinone kullanmaktan kaçınmalı mıyım? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

Pregnancy-safe products to use instead

Products built around the safer ingredients above, scored "no known risks" or "low risk".

Unknown

100

schmidts here now

Sustain Yourself

100

Sustain Yourself Natural Deodorant

Avero

100

Avero Solid Deodorant

Bitamin

100

Bitamin Natural Deodorant N'orange

Mew mew tweet

100

Mew mew tweet Cedar Spruce Baking Soda Free

L'Occitane

100

L´Occitane Powder To-mousse Facial Exfoliator

bareMinerals

99

Complexion Rescue Tinted Hydrating Gel Cream Broad Spectrum SPF 30

Avril

99

Déodorant baume

Salt of the Earth

99

Salt of the Earth Unscented Natural Refillable Roll-on Deodorant

Facetheory

99

facetheory Summer Body Glow B6 SPF 15

Hamilelikte dimethyl imidazolidinone yerine kullanılabilecek güvenli alternatifler | VeriMom

İçerikler — İçerikler

Ayrıca bakın

• dimethyl imidazolidinone hamilelikte güvenli mi?
• dimethyl imidazolidinone bebekler için güvenli mi?
• dimethyl imidazolidinone için hamilelikte güvenli alternatifler nelerdir?

FAQ

dimethyl imidazolidinone hamilelikte güvenli mi?

Multiple supplier SDS and registration records list 1,3‑dimethyl‑2‑imidazolidinone (CAS 80‑73‑9, also called dimethylimidazolidinone, DMI) as Reproductive Toxicity Category 2 (H361, “suspected of damaging fertility or the unborn child”), and ECHA’s Registry of CLH intentions shows a CLH proposal has been submitted for this substance. These items support a suspected reproductive hazard (H361 → h=2) though a legally binding harmonised CLH entry does not appear to be published as an adopted harmonised classification yet; mechanistic data are limited, so mechanism is scored as theoretical only. DMI is a low‑molecular‑weight polar solvent with measurable dermal absorption in typical solvent roles, so topical cosmetic exposure is assessed as moderate. (Sources: ECHA substance page; ECHA Registry of CLH intentions; supplier SDS/C&L notifications; EWG summary).

dimethyl imidazolidinone emzirirken güvenli mi?

Same hazard basis as pregnancy (listed as Repr. Cat.2 / H361 in registration/SDS material and under active CLH proposal). Mechanism evidence is limited. Dermal/topical exposure could lead to systemic exposure (moderate expected dermal absorption), so breastfeeding exposure is scored as moderate (e=2) because systemic maternal exposure could lead to transfer into milk if maternal systemic levels occur.

dimethyl imidazolidinone bebek cildi için güvenli mi?

Hazard and mechanism scores follow the same evidence (H361 / Repr. Cat.2 reporting and CLH proposal). Because DMI has measurable dermal absorption as a small polar solvent, infant skin (0–3 yr) receives a higher exposure score (+1 per guidance) relative to adults, so exposure is scored high. There is no specific infant toxicity data found to alter hazard or mechanism scores.

VeriMom dimethyl imidazolidinone nasıl puanlıyor?

VeriMom dimethyl imidazolidinone'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.

Hamilelikte dimethyl imidazolidinone yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.